10 December 2020 · This Advisory Statement applies to the London region only. RMOC London recommends that the Pan-London Symptom Control Medicines Authorisation and Administration (MAAR) Chart, developed by…
26 November 2020 · A draft toolkit has been produced on Best value biologic – insulin glargine, on behalf of the RMOC system. Insulin glargine is the first medicine managed…
17 November 2020 · The Regional Medicines Optimisation Committee system for England has been developed to address Medicine Optimisation issues which have current impact on practice and where a…
19 October 2020 · Advice was requested from the Regional Medicines Optimisation Committee (RMOC) regarding the most appropriate and practical approach for the ophthalmology monitoring of patients who are…
16 October 2020 · Draft guidance has been produced on Buprenorphine long-acting injection: considerations for opioid substitution treatment use in community settings and secure environments in England, on behalf…
1 May 2020 · The Regional Medicines Optimisation Committee (RMOC, South) has produced an updated advisory statement on the sequential use of biologic medicines which can be accessed below.
28 January 2020 · RMOC North is leading the work on developing an approach to shared care on behalf of the RMOC system, and is seeking comments on the…
17 January 2020 · The Regional Medicines Optimisation Committee (RMOC, South) has produced standard principles for medicines prior approval forms which can be accessed below. The document provides advice…
1 January 2020 · Advice ratified by the Regional Medicines Optimisation Committee (principles drafted by the Medicines Optimisation Clinical Reference Group) has been updated concerning what should be in…
24 December 2019 · The Regional Medicines Optimisation Committee (RMOC, North) has produced a position statement on the prescribing of thiamine and vitamin B complex, which can be accessed…